Remarkably, mice treated with either a low or high dose of cGMP BAFF-R CAR T cells demonstrated rapid tumor clearance and tumor-free survival up to 140 days after tumor challenge (Fig. 2e). This evidence concerns the gene TNFRSF13C and neoplasm.